Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Alnylam Pharmaceuticals has the lowest figure of the 61 pharmaceuticals ranked by one-year price change, at -66.0%, followed by Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%). Figures as of 18 Nov 2026, 15:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Alnylam Pharmaceuticals-66.0%
- Median
- +26.9%
- Combined market value
- PLN 20.55T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | PLN 83.3B | PLN 621.79 | 1.16% down | 66% down | ||
| 2 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | PLN 18.1B | PLN 108.64 | 0.24% up | 64% down | ||
| 3 | Legend BiotechLEGN · Health Care | -42.5% | PLN 12.7B | PLN 65.64 | 1.37% up | 42% down | ||
| 4 | InsmedINSM · Health Care | -40.1% | PLN 106.8B | PLN 486.88 | 0.61% down | 40% down | ||
| 5 | Summit TherapeuticsSMMT · Health Care | -35.6% | PLN 35.7B | PLN 44.62 | 4.03% up | 36% down | ||
| 6 | ZoetisZTS · Health Care | -28.7% | PLN 136.3B | PLN 335.33 | 0.07% down | 29% down | ||
| 7 | ABIVAXABVX · Health Care | -27.3% | PLN 29.5B | PLN 337.26 | 2.19% up | 27% down | ||
| 8 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | PLN 39B | PLN 1,680.53 | 0.93% down | 24% down | ||
| 9 | Cogent BiosciencesCOGT · Health Care | -20.3% | PLN 20B | PLN 115.03 | 2.75% up | 20% down | ||
| 10 | CytokineticsCYTK · Health Care | -20.3% | PLN 29.2B | PLN 209.43 | 0.87% up | 20% down | ||
| 11 | PTC TherapeuticsPTCT · Health Care | -20.2% | PLN 20.4B | PLN 243.60 | 0.40% up | 20% down | ||
| 12 | Abbott LaboratoriesABT · Health Care | -17.0% | PLN 728.5B | PLN 420.64 | 0.07% down | 17% down | ||
| 13 | Novo NordiskNVO · Health Care | -16.9% | PLN 709.3B | PLN 160.93 | 1.63% down | 17% down | ||
| 14 | Corcept TherapeuticsCORT · Health Care | -7.92% | PLN 30.6B | PLN 279.46 | 0.78% down | 8% down | ||
| 15 | Axsome TherapeuticsAXSM · Health Care | -7.37% | PLN 28.4B | PLN 540.37 | 1.12% down | 7% down | ||
| 16 | SanofiSNY · Health Care | -4.08% | PLN 457.9B | PLN 190.68 | 0.20% down | 4% down | ||
| 17 | GrifolsGRFS · Health Care | +1.41% | PLN 23.5B | PLN 34.47 | 0.64% down | 1% up | ||
| 18 | AstraZenecaAZN · Health Care | +2.41% | PLN 1.12T | PLN 722.16 | 1.44% down | 2% up | ||
| 19 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | PLN 50.3B | PLN 60.28 | 1.39% up | 5% up | ||
| 20 | GSKGSK · Health Care | +6.26% | PLN 395.5B | PLN 197.29 | 0.32% down | 6% up | ||
| 21 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | PLN 24.8B | PLN 175.36 | 1.47% up | 10% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | PLN 46.5B | PLN 239.98 | 2.03% up | 11% up | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | PLN 32.8B | PLN 472.41 | 0.78% up | 13% up | ||
| 24 | PfizerPFE · Health Care | +14.4% | PLN 647.8B | PLN 113.65 | 0.69% down | 14% up | ||
| 25 | BeOne MedicinesONC · Health Care | +16.8% | PLN 186B | PLN 1,628.07 | 2.00% down | 17% up | ||
| 26 | BridgeBio PharmaBBIO · Health Care | +17.2% | PLN 60.7B | PLN 311.58 | 0.92% up | 17% up | ||
| 27 | Elanco Animal HealthELAN · Health Care | +20.5% | PLN 52.8B | PLN 105.72 | 1.74% up | 20% up | ||
| 28 | United TherapeuticsUTHR · Health Care | +22.6% | PLN 98.9B | PLN 2,323.18 | 1.06% down | 23% up | ||
| 29 | NovartisNVS · Health Care | +25.0% | PLN 1.19T | PLN 630.53 | 1.43% down | 25% up | ||
| 30 | AbbVieABBV · Health Care | +25.7% | PLN 2.06T | PLN 1,162.82 | 1.21% down | 26% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | PLN 548.4B | PLN 2,162.95 | 0.72% up | 27% up | ||
| 32 | Ascendis PharmaASND · Health Care | +27.8% | PLN 71.2B | PLN 1,085.35 | 0.44% down | 28% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | PLN 24B | PLN 368.38 | 0.34% down | 31% up | ||
| 34 | Belite BioBLTE · Health Care | +31.0% | PLN 25.9B | PLN 637.61 | 0.57% up | 31% up | ||
| 35 | Bristol-Myers SquibbBMY · Health Care | +34.0% | PLN 494.9B | PLN 242.09 | 1.83% down | 34% up | ||
| 36 | Eli LillyLLY · Health Care | +34.9% | PLN 5.01T | PLN 5,629.89 | 1.06% down | 35% up | ||
| 37 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | PLN 399.7B | PLN 3,863.98 | 0.36% up | 36% up | ||
| 38 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | PLN 62.7B | PLN 977.22 | 0.99% up | 37% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | +37.6% | PLN 2.67T | PLN 1,110.20 | 0.90% down | 38% up | ||
| 40 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | PLN 23.9B | PLN 1,193.67 | 1.07% up | 43% up | ||
| 41 | Travere TherapeuticsTVTX · Health Care | +44.2% | PLN 19.5B | PLN 202.92 | 1.21% down | 44% up | ||
| 42 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | PLN 33.3B | PLN 509.55 | 1.68% up | 46% up | ||
| 43 | Merck & CoMRK · Health Care | +50.8% | PLN 1.39T | PLN 565.45 | 1.89% down | 51% up | ||
| 44 | Takeda PharmaceuticalTAK · Health Care | +53.6% | PLN 275.5B | PLN 86.23 | 0.88% down | 54% up | ||
| 45 | AlkermesALKS · Health Care | +58.4% | PLN 31.1B | PLN 184.89 | 1.20% up | 58% up | ||
| 46 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | PLN 34.6B | PLN 1,239.35 | 1.07% up | 61% up | ||
| 47 | GenmabGMAB · Health Care | +70.0% | PLN 128.4B | PLN 208.23 | 0.31% down | 70% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | PLN 199.5B | PLN 171.00 | 0.19% down | 74% up | ||
| 49 | Royalty PharmaRPRX · Health Care | +77.7% | PLN 158.8B | PLN 276.20 | 0.04% up | 78% up | ||
| 50 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | PLN 30.1B | PLN 86.43 | 1.80% up | 83% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | PLN 18.4B | PLN 167.83 | 0.69% down | 88% up | ||
| 52 | Roivant SciencesROIV · Health Care | +90.3% | PLN 113.5B | PLN 156.61 | 0.65% up | 90% up | ||
| 53 | ViatrisVTRS · Health Care | +95.5% | PLN 95B | PLN 82.83 | 0.76% up | 96% up | ||
| 54 | TG TherapeuticsTGTX · Health Care | +107% | PLN 38.6B | PLN 255.26 | 1.26% up | 107% up | ||
| 55 | Dianthus TherapeuticsDNTH · Health Care | +113% | PLN 19.8B | PLN 351.47 | 0.52% up | 113% up | ||
| 56 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | PLN 30.5B | PLN 387.93 | 1.47% up | 126% up | ||
| 57 | Definium TherapeuticsDFTX · Health Care | +169% | PLN 16.2B | PLN 118.26 | 0.14% up | 169% up | ||
| 58 | VeradermicsMANE · Health Care | +233% | PLN 21.4B | PLN 507.15 | 0.41% up | 233% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | +241% | PLN 26.7B | PLN 392.96 | 1.49% up | 241% up | ||
| 60 | Spyre TherapeuticsSYRE · Health Care | +286% | PLN 36.7B | PLN 386.27 | 2.43% up | 286% up | ||
| 61 | ErascaERAS · Health Care | +403% | PLN 19.2B | PLN 54.59 | 2.23% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0198 PLN).
Questions and answers
Which pharmaceuticals have the lowest one-year price change?
Alnylam Pharmaceuticals (-66.0%), Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%) have the lowest one-year price change of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:16 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of PLN 20.55T as of 18 Nov 2026, 15:16 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.